PACKAGE LEAFLET: INFORMATION FOR THE USER. Active substance: enoximone
|
|
- Todd Sullivan
- 5 years ago
- Views:
Transcription
1 PACKAGE LEAFLET 1
2 PACKAGE LEAFLET: INFORMATION FOR THE USER Perfan Injection 100 mg/20 ml Concentrate for Solution for Injection Active substance: enoximone Read all of this leaflet carefully before you start using this medicine. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. - If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. In this leaflet: 1. What Perfan Injection is and what it is used for 2. Before you use Perfan Injection 3. How to use Perfan Injection 4. Possible side effects 5. How to store Perfan Injection 6. Further information 1. WHAT PERFAN INJECTION IS AND WHAT IT IS USED FOR Perfan Injection contains a drug called enoximone. Perfan Injection makes your heart pump more strongly. It is used to treat congestive heart failure (CHF) in adults. CHF is when your heart cannot pump enough blood around your body. This leads to a build up of fluid in your limbs, lungs and other organs. 2. BEFORE YOU USE PERFAN INJECTION Do not use Perfan Injection - if you are allergic (hypersensitive) to enoximone or any of the other ingredients of Perfan Injection. See Section 6 for a list of other ingredients. Take special care with Perfan Injection if you have - a thickened heart muscle (hypertrophic cardiomyopathy) - narrowed or blocked heart valves (stenotic or obstructive valvular disease) - narrowed or blocked blood vessels (outlet obstruction) - severe congestive heart failure. You may have an increased risk for irregular heart beat. Use in children: Perfan Injection is not recommended for use in children. During treatment with Perfan Injection, you will have extra tests to check: - your blood pressure and heart rate. If your blood pressure becomes too low, you will be given Perfan Injection more slowly, or it might be stopped. - your heart rhythm. If you have an irregular heart beat, it can become more irregular, and your heart might stop. - your electrolyte levels (the amounts of different chemicals in your blood). In particular your blood potassium levels will be monitored. If you have raised potassium levels you are more likely to get an irregular heartbeat (arrhythmia). This is especially likely if you are taking 2
3 digoxin (another heart medicine). The doses of other drugs you are taking might be changed to keep your heart beat regular. - your fluid levels and your kidney function. These will be measured by blood tests and by how much urine you produce. If you produce more urine your doctor may need to reduce the dose of any diuretics (water tablets) you are taking. If your fluid levels fall too low Perfan Injection will not work for you. - your blood platelets (a type of blood cell which helps your blood to clot) - your liver enzyme levels. If you have increases in some liver enzyme levels your doctor may stop your Perfan Injection. Taking other medicines Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. You must take special care if you are taking any of the following medicines: - digoxin (a heart medicine) Using Perfan Injection with food and drink You should ask your doctor about what you can eat or drink. Pregnancy and breast-feeding Ask your doctor or pharmacist for advice before taking any medicine. Tell your doctor if you are pregnant or breast-feeding. If you are pregnant or breast-feeding, you should not be given Perfan Injection unless it is clearly necessary. Driving and using machines Ask your doctor or pharmacist for advice. Important information about some of the ingredients of Perfan Injection This medicinal product contains small amounts (less than 100 mg/ml) of ethanol (alcohol). This medicinal product contains less than 1 mmol sodium (23 mg), i.e. essentially sodium-free. 3. HOW TO USE PERFAN INJECTION You will be given Perfan Injection by a doctor or nurse. Your doctor will decide on how much you need and when it is to be given. The dose will depend on the condition of your heart and your response to the drug, as well as, on the concomitant therapies which you receive while you are on enoximone. Perfan Injection will be diluted before use. Perfan Injection will be given to you as a slow intravenous injection (injection into a vein) or continuous infusion (drip into a vein over a longer period of time). You will only be given Perfan Injection if you are in hospital. The duration of your treatment will depend on how you respond, which means whether and how rapidly your heart condition will improve. You will normally be given Perfan Injection for less than 24 hours unless your heart condition requires a longer duration of treatment. If you think you have been given too much Perfan Injection If you are given too much Perfan Injection: - you may feel dizzy - you may feel faint 3
4 - you may feel sick - your vision may become blurred - you may feel that your heart is beating rapidly (palpitations). If you develop any of these symptoms you must inform your doctor immediately. Your dose of Perfan Injection may be reduced or stopped. You will be given treatment depending on your symptoms. If you stop using Perfan Injection Your doctor will decide when to stop giving you this medicine. If you have any further questions on the use of this product, ask your doctor. 4. POSSIBLE SIDE EFFECTS Like all medicines, Perfan Injection can cause side effects, although not everybody gets them. If you have the following side effects tell your doctor immediately. Your doctor may have to reduce your dose or stop giving you Perfan Injection. ventricular tachycardia (rapid heart beat) supraventricular arrhythmia e.g. ectopia (extra heart beats) tachyarrhythmia (disturbance of the heart rhythm also causing rapid heart beat). These are uncommon but serious side effects and your doctor may stop your treatment. hypotension (low blood pressure). This is a common side effect and may cause you to: feel dizzy, faint or sick have blurred vision feel that your heart is beating rapidly (palpitations) The following side effects have also been reported with Perfan Injection: Common (less than 1 in 10, but more than 1 in 100 patients): insomnia (difficulty in sleeping) headache platelet count reduction (without symptoms) rise in liver enzyme levels (transaminases) and bilirubin (a bile pigment). These can indicate liver problems. Uncommon (less than 1 in 100, but more than 1 in 1000 patients): dizziness vomiting (being sick) nausea (feeling sick) diarrhoea slight rise in blood glucose and alkaline phosphatase slight rise in leukocytes (white blood cells, particularly neutrophils and eosinophils) slight decrease in haematocrit (total volume of red blood cells) and haemoglobin (a red blood cell protein) slight rise in urea, creatinine or uric acid. These can indicate a kidney problem. Rare (less than 1 in 1000, but more than 1 in 10,000 patients): fever chills inability to pass urine (urinary retention) decreased production of urine (oliguria) 4
5 fluid retention (e.g. swollen ankles) thrombophlebitis (an inflamed blood clot in a vein) at the site of injection irritation muscle pain in extremities (pain in the hands or feet) Very rare (less than 1 in 10,000 patients): ventricular fibrillation (when your heart contracts in an uncoordinated way). This is a very rare but very serious side effect that will require urgent emergency treatment. It is more likely at doses of more than 3 mg/kg body weight. If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. 5. HOW TO STORE PERFAN INJECTION Store below 30 C and keep out of the reach and sight of children. Perfan Injection should not be given to you after the expiry date which is stated on the label after Exp.:. The expiry date refers to the last day of that month. You should not be given Perfan Injection if there are crystals in the solution. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment. 6. FURTHER INFORMATION What Perfan 5 mg/ml Injection contains - The active substance is enoximone - The other ingredients are: - ethanol - sodium hydroxide - propylene glycol - water for injections What Perfan 5 mg/ml Injection looks like and contents of the pack Perfan Injection is a clear, bright yellow solution containing 5 mg/ml enoximone. Perfan Injection is supplied in 20 ml glass ampoules containing 100 mg enoximone. Cartons containing 5 or 10 ampoules are provided. Not all pack sizes may be marketed. Marketing Authorisation Holder and Manufacturer CARINOPHARM GmbH Bahnhofstr Elze Germany 5
6 Phone: +49 (0) Fax: +49 (0) This leaflet was last revised in 08/ The following information is intended for medical or healthcare professionals only: Product Summary Trade Name of the Medicinal Product Perfan Injection Qualitative and Quantitative Composition 5 mg/ml solution of enoximone presented in ampoules containing 20 ml. Pharmaceutical Form Solution for injection Clinical Particulars Therapeutic Indications Perfan Injection is indicated for the treatment of congestive heart failure, typically where cardiac output is reduced and filling pressures increased, in patients who require intravenous therapy and who can be closely monitored. The duration of therapy should depend on the patient s continued positive and beneficial response. Sustained haemodynamic and clinical effects have been observed in patients treated for up to 48 hours. Posology and method of administration Perfan Injection is for intravenous administration (slow injection or continuous infusion) and must be diluted before use. Dilution Perfan Injection must be diluted with an equal volume of 0.9% sodium chloride injection or water for injections before administration. Do not use more dilute solutions or other diluents, particularly dextrose injection, as crystal formation may occur. Use only plastic containers or syringes for dilutions. Crystal formation has been observed within approximately 1 hour after mixing Perfan Injection in glass containers or syringes. Other drugs or fluids must not be mixed in the same container or administered concomitantly in the same infusion line as Perfan Injection. In-use shelf-life Chemical and physical in-use stability has been demonstrated for 24 hours at 5 C and 25 C. From a microbiological point of view, the product should be used immediately. If not used immediately, inuse storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at room temperature unless dilution has taken place in controlled and validated aseptic conditions. After dilution, the product must be stored at room temperature. Dilutions must not be refrigerated as crystal formation may occur. Administration Initial Therapy 6
7 Therapy should be initiated with a dose of mg/kg given as a slow intravenous injection (not faster than 12.5 mg/min); further doses of 0.5 mg/kg may be given similarly every 30 minutes until a satisfactory response is achieved or a total initial dose of 3.0 mg/kg is reached. Alternatively treatment may be initiated as an infusion at a rate of 90 micrograms/kg/minute administered over minutes until the required haemodynamic response is achieved. Maintenance Therapy To maintain the effects of Perfan Injection the initial dose (not more than 3.0 mg/kg) may be repeated as required every 3 6 hours and adjusted according to the response of the patient. Alternatively, a continuous or intermittent infusion at a rate of 5 20 micrograms/kg/minute may be instituted. The total dose over 24 hours should not normally exceed 24.0 mg/kg. In patients with renal impairment the dosage or dosage frequency may need to be reduced. Precautions should be taken to avoid venous extravasation during administration. The ph of undiluted Perfan Injection is approximately Perfan Injection is not recommended for use in children. Management of adverse reactions Arrhythmias The occurrence of severe supraventricular and ventricular arrhythmias may require immediate discontinuation of Perfan Injection and institution of appropriate antiarrhythmic therapy. Platelet count reduction Platelet counts before and during therapy are recommended. Gastrointestinal side effects Severe gastrointestinal side effects may be managed by reducing dosage, or if necessary, administration of Perfan Injection may be temporarily interrupted. Increases in hepatic enzyme levels It is recommended to monitor patients for changes in hepatic enzyme levels. If clinically significant increases in hepatic enzymes occur following the intravenous administration of Perfan Injection, therapy should be discontinued. 7
PACKAGE LEAFLET: INFORMATION FOR THE USER. Dopamine 40 mg/ml Sterile Concentrate
PACKAGE LEAFLET: INFORMATION FOR THE USER Dopamine 40 mg/ml Sterile Concentrate Read all of this leaflet carefully before you start using this medicine. Keep this leaflet. You may need to read it again.
More informationPackage leaflet: Information for the patient Tranexamic acid 100 mg/ml Solution for Injection tranexamic acid
Package leaflet: Information for the patient Tranexamic acid 100 mg/ml Solution for Injection tranexamic acid Read all of this leaflet carefully before you are given this medicine because it contains important
More informationPackage leaflet: Information for the patient. Tranexamic Acid 100 mg/ml, Solution for Injection tranexamic acid
Package leaflet: Information for the patient Tranexamic Acid 100 mg/ml, Solution for Injection tranexamic acid Read all of this leaflet carefully before you are given this medicine because it contains
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Zoledronic Acid IBIGEN 4 mg powder and solvent for solution for infusion Zoledronic acid
PACKAGE LEAFLET: INFORMATION FOR THE USER Zoledronic Acid IBIGEN 4 mg powder and solvent for solution for infusion Zoledronic acid Read all of this leaflet carefully before you are given Zoledronic Acid
More informationPackage leaflet: Information for the patient. NEGABAN 1g, powder for solution for injection or infusion Temocillin
Package leaflet: Information for the patient NEGABAN 1g, powder for solution for injection or infusion Temocillin Read all of this leaflet carefully before you start using this medicine because it contains
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. SODIPHOS 22mEq / 10ml Concentrate for solution for infusion. Disodium phosphate dihydrate
PACKAGE LEAFLET: INFORMATION FOR THE USER SODIPHOS 22mEq / 10ml Concentrate for solution for infusion Disodium phosphate dihydrate Read all of this leaflet carefully before you start using this medicine.
More informationPackage Leaflet: Information for the User Zotron 4mg/2ml (ή 8mg/4ml) Solution for Injection or Infusion ondansetron
Package Leaflet: Information for the User Zotron 4mg/2ml (ή 8mg/4ml) Solution for Injection or Infusion ondansetron Read all of this leaflet carefully before you start taking this medicine because it contains
More informationPackage leaflet: Information for the user. Lidocaine Hydrochloride 1% w/v Solution for Injection Lidocaine Hydrochloride
Package leaflet: Information for the user Lidocaine Hydrochloride 1% w/v Solution for Injection Lidocaine Hydrochloride Read all of this leaflet carefully before you start using this medicine because it
More informationVentolin Injection 500 micrograms/ml salbutamol sulfate
Package leaflet: Information for the user Ventolin Injection 500 micrograms/ml salbutamol sulfate Read all of this leaflet carefully before you start taking this medicine because it contains important
More informationPackage leaflet: Information for the user. Novastan 100 mg/ml concentrate for solution for infusion. argatroban monohydrate
Package leaflet: Information for the user 100 mg/ml concentrate for solution for infusion argatroban monohydrate Read all of this leaflet carefully before you start using this medicine because it contains
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. EPHEDRINE HCl STEROP 10mg/ml EPHEDRINE HCl STEROP 50mg/ml Solution for injection. Ephedrine Hydrochloride
PACKAGE LEAFLET: INFORMATION FOR THE USER EPHEDRINE HCl STEROP 10mg/ml EPHEDRINE HCl STEROP 50mg/ml Solution for injection Ephedrine Hydrochloride Read all of this leaflet carefully before you start using
More informationPackage leaflet: Information for the user Zinforo 600 mg powder for concentrate for solution for infusion Ceftaroline fosamil
Package leaflet: Information for the user Zinforo 600 mg powder for concentrate for solution for infusion Ceftaroline fosamil Read all of this leaflet carefully before you start using this medicine because
More informationPackage leaflet: Information for the user. Exembol 1 mg/ml solution for infusion. argatroban monohydrate
Package leaflet: Information for the user Exembol 1 mg/ml solution for infusion argatroban monohydrate Read all of this leaflet carefully before you start using this medicine because it contains important
More information1. What Miacalcic is and what it is used for
Package leaflet: Information for the user Miacalcic 100 IU/ml solution for injection and infusion Calcitonin (salmon, synthetic) Read all of this leaflet carefully before you start using this medicine
More informationPackage leaflet: Information for the user. Tobramycin 40 mg/ml Solution for Injection tobramycin
Package leaflet: Information for the user Tobramycin 40 mg/ml Solution for Injection tobramycin Read all of this leaflet carefully before you start using this medicine because it contains important information
More informationPackage leaflet: Information for the user. TRISENOX 1 mg/ml concentrate for solution for infusion arsenic trioxide
Package leaflet: Information for the user TRISENOX 1 mg/ml concentrate for solution for infusion arsenic trioxide Read all of this leaflet carefully before you start using this medicine because it contains
More informationSodium Chloride 0.9% w/v Intravenous Infusion BP Solution for Infusion Sodium chloride
Package leaflet: Information for the user Sodium Chloride 0.9% w/v Intravenous Infusion BP Solution for Infusion Sodium chloride Read all of this leaflet carefully before using this medicine because it
More informationPackage leaflet: Information for the user Cyklokapron 500 mg Solution for Injection tranexamic acid
Package leaflet: Information for the user Cyklokapron 500 mg Solution for Injection tranexamic acid Read all of this leaflet carefully before you are given this medicine because it contains important information
More informationPackage leaflet: Information for the user. Elaprase 2 mg/ml concentrate for solution for infusion idursulfase
Package leaflet: Information for the user Elaprase 2 mg/ml concentrate for solution for infusion idursulfase This medicine is subject to additional monitoring. This will allow quick identification of new
More informationPackage leaflet: Information for the user. HEPATECT CP 50 IU/ml solution for infusion. Human hepatitis B immunoglobulin for intravenous administration
: Information for the user HEPATECT CP 50 IU/ml solution for infusion Human hepatitis B immunoglobulin for intravenous administration Read all of this leaflet carefully before you start using this medicine
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Human Albumin Biotest 20%, solution for infusion Human albumin
PACKAGE LEAFLET: INFORMATION FOR THE USER Human Albumin Biotest 20%, solution for infusion Human albumin Read this entire leaflet carefully before you start using this medicine, because it contains important
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Fibrovein 3%, 1%, 0.5% and 0.2% Solution for Injection Sodium tetradecyl sulphate
PACKAGE LEAFLET: INFORMATION FOR THE USER Fibrovein 3%, 1%, 0.5% and 0.2% Solution for Injection Sodium tetradecyl sulphate Read all of this leaflet carefully before you start using this medicine. Keep
More informationPackage leaflet: Information for the user
Package leaflet: Information for the user Lartruvo 10 mg/ml concentrate for solution for infusion olaratumab This medicine is subject to additional monitoring. This will allow quick identification of new
More information1. WHAT OXCARBAZEPINE IS AND WHAT IT IS USED FOR
PACKAGE LEAFLET: INFORMATION FOR THE USER Oxcarbazepine 150/300/600 mg Film-Coated Tablets (Oxcarbazepine) Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You
More informationCOMPANY CORE PACKAGE INSERT CCPI (PI/CORE/ENGLISH)
COMPANY CORE PACKAGE INSERT CCPI (PI/CORE/ENGLISH) HUMAN ALBUMIN 20 % BEHRING Rev.: 05-MAR-2008 / PEI approval 26.02.08 Supersedes previous versions Rev.: 28-NOV-2007 / Adaptation to Core SPC Rev.: 02-JAN-2007
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER Doxorubicin 2mg/ml Concentrate for solution for infusion Referred to in this leaflet as Doxorubicin 2mg/ml
PACKAGE LEAFLET: INFORMATION FOR THE USER Doxorubicin 2mg/ml Concentrate for solution for infusion Referred to in this leaflet as Doxorubicin 2mg/ml Read all of this leaflet carefully before you start
More informationHavrix Monodose Vaccine Hepatitis A Vaccine (Inactivated, adsorbed) ELISA Units/1 ml Suspension for Injection in a pre-filled syringe
GSK (logo) Package Leaflet: Information for the User Havrix Monodose Vaccine Hepatitis A Vaccine (Inactivated, adsorbed). 1440 ELISA Units/1 ml Suspension for Injection in a pre-filled syringe Read all
More informationPackage leaflet: Information for the patient. Morphine Unimedic 1 mg/ml solution for injection morphine hydrochloride trihydrate
Package leaflet: Information for the patient Morphine Unimedic 1 mg/ml solution for injection morphine hydrochloride trihydrate Read all of this leaflet carefully before you start using this medicine because
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER Etoposide Accord 20 mg/ml Concentrate for Solution for Infusion Etoposide
PACKAGE LEAFLET: INFORMATION FOR THE USER Etoposide Accord 20 mg/ml Concentrate for Solution for Infusion Etoposide Read all of this leaflet carefully before you start taking this medicine because it contains
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Calcium Folinate 10 mg/ml Injection
PACKAGE LEAFLET: INFORMATION FOR THE USER Calcium Folinate 10 mg/ml Injection Read all of this leaflet carefully before you start using this medicine. Keep this leaflet. You may need to read it again.
More informationPackage leaflet: Information for the patient. Konakion MM Ampoules 10mg/ml solution for injection and oral solution Phytomenadione (vitamin K 1 )
Package leaflet: Information for the patient Konakion MM Ampoules 10mg/ml solution for injection and oral solution Phytomenadione (vitamin K 1 ) Roche Read all of this leaflet carefully before you start
More informationArtesunate 60 mg for injection WHOPAR part 3 June 2013 (Guilin Pharmaceutical Co., Ltd.), MA051 PATIENT INFORMATION LEAFLET
PATIENT INFORMATION LEAFLET 1 PATIENT INFORMATION LEAFLET: INFORMATION FOR THE USER Artesun * Artesunate 60 mg for injection and sodium bicarbonate injection 50 mg/ml (1ml) and sodium chloride injection
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Glucose Intravenous Infusion BP 10% w/v solution for infusion Glucose (as glucose monohydrate)
PACKAGE LEAFLET: INFORMATION FOR THE USER Glucose Intravenous Infusion BP 10% w/v solution for infusion Glucose (as glucose monohydrate) Read all of this leaflet carefully before you start using this medicine
More informationIrbenida H 150mg/12,5mg film-coated tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER Irbenida H 150mg/12,5mg film-coated tablets IRBESARTAN/HYDROCHLOROTHIAZIDE This leaflet is a copy of the Summary of Product Characteristics and Patient Information
More informationPackage leaflet: Information for the patient. Lacosamide G.L. 10 mg/ml solution for infusion lacosamide
Package leaflet: Information for the patient Lacosamide G.L. 10 mg/ml solution for infusion lacosamide Read all of this leaflet carefully before you start using this medicine because it contains important
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Dantrium 25 mg Capsules / Dantrium 100 mg Capsules Dantrolene sodium
PACKAGE LEAFLET: INFORMATION FOR THE USER Dantrium 25 mg Capsules / Dantrium 100 mg Capsules Dantrolene sodium Read all of this leaflet carefully before you start taking this medicine because it contains
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. SALAGEN 5 mg film-coated tablets. Pilocarpine hydrochloride
PACKAGE LEAFLET: INFORMATION FOR THE USER SALAGEN 5 mg film-coated tablets Pilocarpine hydrochloride Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may
More informationPackage leaflet: Information for the patient. Zerbaxa 1 g / 0.5 g powder for concentrate for solution for infusion ceftolozane / tazobactam
Package leaflet: Information for the patient Zerbaxa 1 g / 0.5 g powder for concentrate for solution for infusion ceftolozane / tazobactam This medicine is subject to additional monitoring. This will allow
More informationSome general information on hepatitis A infection is given at the end of this leaflet.
Package Leaflet: Information for the User Havrix Monodose Vaccine Suspension for injection in a pre-filled syringe Hepatitis A (inactivated) vaccine (adsorbed) Read all of this leaflet carefully before
More informationPackage leaflet: Information for the patient. Chlorphenamine 10 mg/ml Solution for Injection (Chlorphenamine Maleate)
Package leaflet: Information for the patient Chlorphenamine 10 mg/ml Solution for Injection (Chlorphenamine Maleate) Read all of this leaflet carefully before you start taking this medicine because it
More informationPackage leaflet: Information for the patient. Vyxeos 44 mg/100 mg powder for concentrate for solution for infusion daunorubicin and cytarabine
Package leaflet: Information for the patient Vyxeos 44 mg/100 mg powder for concentrate for solution for infusion daunorubicin and cytarabine Read all of this leaflet carefully before you start taking
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER
a Novartis Company PACKAGE LEAFLET: INFORMATION FOR THE USER Pantoprazole Read all of this leaflet carefully before you start using this medicine. - Keep this leaflet. You may need to read it again. -
More informationPackage leaflet: Information for the user
CSL Behring Package leaflet: Information for the user Alburex 5, 50 g/l, solution for infusion & Alburex 20, 200 g/l, solution for infusion Human albumin Read all of this leaflet carefully before you are
More information2. What you need to know before you are given Konakion MM. Package Leaflet: Information for the patient
Package Leaflet: Information for the patient Konakion MM Ampoules 10mg/ml solution for injection Phytomenadione (vitamin K 1 ) Roche Read all of this leaflet carefully before you start taking this medicine
More informationPackage leaflet: Information for the user
Package leaflet: Information for the user Lidocaine Accord 10 mg/ml solution for injection Lidocaine Accord 20 mg/ml solution for injection Lidocaine hydrochloride Read all of this leaflet carefully before
More informationPackage leaflet: Information for the user. Cyanokit 5 g powder for solution for infusion hydroxocobalamin
Package leaflet: Information for the user Cyanokit 5 g powder for solution for infusion hydroxocobalamin Read all of this leaflet carefully before using this medicine because it contains important information
More information1. What Faslodex is and what it is used for
Package leaflet: Information for the user Faslodex 250 mg solution for injection Fulvestrant Read all of this leaflet carefully before you start using this medicine because it contains important information
More informationPACKAGE LEAFLET: INFORMATION FOR THE PATIENT. Dobutamine 12.5mg/ml Concentrate for Solution for Infusion Dobutamine Hydrochloride
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT Dobutamine 12.5mg/ml Concentrate for Solution for Infusion Dobutamine Hydrochloride Read all of this leaflet carefully before you start using this medicine
More informationPackage leaflet: Information for the patient. Trasylol 10,000 KIU/ml solution for injection or infusion. Aprotinin
Package leaflet: Information for the patient Trasylol 10,000 KIU/ml solution for injection or infusion Aprotinin Read all of this leaflet carefully before you are given this medicine because it contains
More informationPackage leaflet: Information for the user
Package leaflet: Information for the user Irbesartan 75mg Film-coated Tablets Irbesartan 150mg Film-coated Tablets Irbesartan 300mg Film-coated Tablets irbesartan Read all of this leaflet carefully before
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. EASOFEN MAX STRENGTH 400mg FILM-COATED TABLETS. Ibuprofen
PACKAGE LEAFLET: INFORMATION FOR THE USER EASOFEN MAX STRENGTH 400mg FILM-COATED TABLETS Ibuprofen Read all of this leaflet carefully before you start taking Easofen Max Strength Tablets because it contains
More informationAngina normally feels like a tight pain in the chest, neck or arm area.
Isoket 1 mg/ml Concentrate for solution for injection or infusion Isosorbide Dinitrate 10 ml ampoule Patient Information Leaflet Read all of this leaflet carefully before you start using this medicine.
More informationPATIENT / USER INFORMATION LEAFLET. Cinryze 500 Units powder and solvent for solution for injection C1 inhibitor (human)
PATIENT / USER INFORMATION LEAFLET Cinryze 500 Units powder and solvent for solution for injection C1 inhibitor (human) Read all of this leaflet carefully before you start taking this medicine. Keep this
More informationPackage leaflet: Information for the user
Package leaflet: Information for the user Cisatracurium 2 mg/ml Solution for injection/ infusion Cisatracurium 5 mg/ml Solution for injection/ infusion Cisatracurium The name of your medicine are Cisatracurium
More informationPackage leaflet: Information for the user. Portrazza 800 mg concentrate for solution for infusion necitumumab
Package leaflet: Information for the user Portrazza 800 mg concentrate for solution for infusion necitumumab This medicine is subject to additional monitoring. This will allow quick identification of new
More informationPackage leaflet: Information for the user. Bupivacaine 0.25% w/v, 0.5% w/v solution for injection Bupivacaine Hydrochloride
Package leaflet: Information for the user Bupivacaine 0.25% w/v, 0.5% w/v solution for injection Bupivacaine Hydrochloride Read all of this leaflet carefully before you start using this medicine because
More informationPackage leaflet: Information for the user
Package leaflet: Information for the user Rhesonativ 750 IU/ml, solution for injection Human anti-d immunoglobulin Read all of this leaflet carefully before you start taking this medicine because it contains
More informationPackage leaflet: Information for the patient. Torarese 2.5 mg tablets Torarese 5 mg tablets Torarese 10 mg tablets Torarese 20 mg tablets.
Package leaflet: Information for the patient Torarese 2.5 mg tablets Torarese 5 mg tablets Torarese 10 mg tablets Torarese 20 mg tablets Torasemide Read all of this leaflet carefully before you start taking
More informationPackage Leaflet: Information for the User Zyloric 100 mg and 300 mg tablets allopurinol
Package Leaflet: Information for the User Zyloric 100 mg and 300 mg tablets allopurinol Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may need to read
More informationPackage leaflet: Information for the user. Methylthioninium chloride Proveblue 5 mg/ml solution for injection Methylthioninium chloride
Package leaflet: Information for the user Methylthioninium chloride Proveblue 5 mg/ml solution for injection Methylthioninium chloride Read all of this leaflet carefully before you are given this medicine
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Cisatracurium 2 mg/ml Solution for Injection/Infusion Cisatracurium 5 mg/ml Solution for Injection/Infusion
PACKAGE LEAFLET: INFORMATION FOR THE USER Cisatracurium 2 mg/ml Solution for Injection/Infusion Cisatracurium 5 mg/ml Solution for Injection/Infusion Cisatracurium Read all of this leaflet carefully before
More informationPackage leaflet: Information for the user. Zoledronic Acid Accord 4 mg/5 ml concentrate for solution for infusion Zoledronic acid
Package leaflet: Information for the user Zoledronic Acid Accord 4 mg/5 ml concentrate for solution for infusion Zoledronic acid Read all of this leaflet carefully before you start taking this medicine
More informationPackage leaflet: Information for the user. Cefixime ABR 100 mg/5 ml powder for oral suspension Cefixime
Package leaflet: Information for the user Cefixime ABR 100 mg/5 ml powder for oral suspension Cefixime Read all of this leaflet carefully before you start taking this medicine because it contains important
More informationPackage leaflet: Information for the user. Calcium Folinate 10 mg/ml, solution for injection Calcium folinate
Package leaflet: Information for the user Calcium Folinate 10 mg/ml, solution for injection Calcium folinate Read all of this leaflet carefully before you start using this medicine because it contains
More informationPyrazinamide 500 mg Tablets (Macleods Pharmaceuticals Ltd), TB243. WHOPAR part 3 April 2014 Section 6 updated: May 2014 PACKAGE LEAFLET.
PACKAGE LEAFLET Page 1 of 6 PACKAGE LEAFLET: INFORMATION FOR THE USER Pyrazinamide 500 mg Tablets * Pyrazinamide Read all of this leaflet carefully before you start taking this medicine. - Keep this leaflet.
More informationPackage leaflet: Information for the patient. Heparin Sodium BP 1000 IU/L in 0.9% w/v Sodium Chloride IV Infusion. Active substance: Heparin Sodium
Package leaflet: Information for the patient Heparin Sodium BP 1000 IU/L in 0.9% w/v Sodium Chloride IV Infusion Active substance: Heparin Sodium Read all of this leaflet carefully before you are given
More informationPackage Leaflet: Information for the User
Package Leaflet: Information for the User KLEAN-PREP 69g Sachet Powder for Oral Solution Macrogol 3350, Sodium sulphate anhydrous, Sodium bicarbonate, Sodium chloride and Potassium chloride Read all of
More informationZANOSAR 1g. STREPTOZOCINE Lyophilised powder for solution for injection
PACKAGE LEAFLET: INFORMATION FOR THE USER ZANOSAR 1g STREPTOZOCINE Lyophilised powder for solution for injection Read all of this leaflet carefully before you start using this medicine. Keep this leaflet.
More informationPackage leaflet: Information for the patient. Dexametason Abcur 4 mg tablets. Dexamethasone
Package leaflet: Information for the patient Dexametason Abcur 1 mg tablets Dexametason Abcur 4 mg tablets Dexamethasone Read all of this leaflet carefully before you start taking this medicine because
More informationPACKAGE LEAFLET: INFORMATION FOR THE PATIENT. ILAXTEN 20 MG TABLETS bilastine
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT ILAXTEN 20 MG TABLETS bilastine Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
More informationPATIENT INFORMATION LEAFLET
PATIENT INFORMATION LEAFLET Page 1 of 6 PATIENT INFORMATION LEAFLET: INFORMATION FOR THE USER 1 ethambutol hydrochloride Read all of this leaflet carefully before your child starts taking this medicine
More informationLEUCOVORIN-TEVA 10 mg/ml CONCENTRATE FOR SOLUTION FOR INFUSION folinic acid as the calcium salt PACKAGE LEAFLET: INFORMATION FOR THE USER
LEUCOVORIN-TEVA 10 mg/ml CONCENTRATE FOR SOLUTION FOR INFUSION folinic acid as the calcium salt PACKAGE LEAFLET: INFORMATION FOR THE USER Read all of this leaflet carefully before you start using this
More informationPackage leaflet: Information for the user. Busulfan 6 mg/ml concentrate for solution for infusion busulfan
Package leaflet: Information for the user Busulfan 6 mg/ml concentrate for solution for infusion busulfan Read all of this leaflet carefully before you start using this medicine because it contains important
More informationPotassium Chloride 0.3% w/v and Sodium Chloride 0.9% w/v Solution for Infusion Potassium chloride and sodium chloride
Package leaflet: Information for the user Potassium Chloride 0.3% w/v and Sodium Chloride 0.9% w/v Solution for Infusion Potassium chloride and sodium chloride Read all of this leaflet carefully before
More informationPrimacor Injection Milrinone Lactate
Primacor Injection Milrinone Lactate CONSUMER MEDICINE INFORMATION Please read this leaflet before you start taking this medicine What is in this leaflet? This leaflet answers some common questions about
More informationIrbenida 150 mg film-coated tablets; 300 mg film-coated tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER Irbenida 150 mg film-coated tablets; 300 mg film-coated tablets IRBESARTAN This leaflet is a copy of the Summary of Product Characteristics and Patient Information
More informationPackage leaflet: Information for the user. Aminoven 5% Solution for infusion Aminoven 10% Solution for infusion Aminoven 15% Solution for infusion
Package leaflet: Information for the user Aminoven 5% Solution for infusion Aminoven 10% Solution for infusion Aminoven 15% Solution for infusion Read all of this leaflet carefully before you start using
More information1. What Octostim Nasal Spray is and what it is used for
Package Leaflet: Information for the User Octostim 1.5 mg/ml Nasal Spray Desmopressin acetate Read all of this leaflet carefully before you start using this medicine because it contains important information
More informationPackage leaflet: Information for the user Venofer 20 mg iron /ml Solution for injection or concentrate for solution for infusion Iron Sucrose
Package leaflet: Information for the user 20 mg iron /ml Solution for injection or concentrate for solution for infusion Iron Sucrose This medicine is subject to additional monitoring. This will allow
More informationPackage leaflet: Information for the user. DaunoXome Injection 2mg/ml Concentrate for Solution for Infusion Daunorubicin
Package leaflet: Information for the user DaunoXome Injection 2mg/ml Concentrate for Solution for Infusion Daunorubicin Read all of this leaflet carefully before you start using this medicine because it
More informationPackage leaflet: Information for the user. <PRODUCT NAME> 10 g powder for oral solution in sachet Macrogol 4000
Package leaflet: Information for the user 10 g powder for oral solution in sachet Macrogol 4000
More informationPackage leaflet: Information for the user
Package leaflet: Information for the user Menveo powder and solution for solution for injection Meningococcal Group A, C, W135 and Y conjugate vaccine Read all of this leaflet carefully before you or your
More informationPACKAGE LEAFLET DIASTABOL 50 MG TABLETS. Version 1.0 1
PACKAGE LEAFLET DIASTABOL 50 MG TABLETS 1 PACKAGE LEAFLET: INFORMATION FOR THE USER Diastabol 50 mg tablets miglitol Read all of this leaflet carefully before you start taking this medicine. - Keep this
More informationArtesunate 60 mg for injection WHOPAR part 3 November 2015 (Guilin Pharmaceutical Co., Ltd.), MA051 PATIENT INFORMATION LEAFLET
PATIENT INFORMATION LEAFLET 1 PATIENT INFORMATION LEAFLET: INFORMATION FOR THE USER Artesun 60mg * Artesunate 60 mg for injection and sodium bicarbonate injection 50 mg/ml (1ml) and sodium chloride injection
More informationPackage leaflet: Information for the user. SenEase 7.5 mg tablets. Sennosides
Package leaflet: Information for the user SenEase 7.5 mg tablets Sennosides Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Keep
More informationPackage leaflet: Information for the user. Chirocaine mg/ml or 1.25 mg/ml solution for infusion For epidural use only.
Package leaflet: Information for the user Chirocaine 0.625 mg/ml or 1.25 mg/ml solution for infusion For epidural use only Levobupivacaine Read all of this leaflet carefully before you start taking this
More informationD-Gam 250 micrograms/ml. Solution for injection. human anti-d immunoglobulin
Package leaflet: Information for the patient D-Gam 50 micrograms/ml D-Gam 250 micrograms/ml Solution for injection human anti-d immunoglobulin Read all of this leaflet carefully before you start using
More informationPackage leaflet: Information for the user. GlucaGen HypoKit 1 mg Powder and solvent for solution for injection Glucagon
Package leaflet: Information for the user GlucaGen HypoKit 1 mg Powder and solvent for solution for injection Glucagon Read all of this leaflet carefully before you are given this injection because it
More informationPackage leaflet: Information for the patient. ERWINASE 10,000 Units, Powder for solution for injection
PACKAGE LEAFLET 1 Package leaflet: Information for the patient ERWINASE 10,000 Units, Powder for solution for injection (Asparaginase from Erwinia chrysanthemi; Erwinia L-asparaginase) Read all of this
More informationPackage leaflet: Information for the user. Omnilax 10 g powder for oral solution, sachet. Macrogol 4000
Package leaflet: Information for the user Omnilax 10 g powder for oral solution, sachet Macrogol 4000 Read all of this leaflet carefully before you start taking this medicine because it contains important
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Cisatracurium 2 mg/ml solution for injection/infusion Cisatracurium 5 mg/ml solution for injection/infusion
PACKAGE LEAFLET: INFORMATION FOR THE USER Cisatracurium 2 mg/ml solution for injection/infusion Cisatracurium 5 mg/ml solution for injection/infusion Cisatracurium Read all of this leaflet carefully before
More informationPATIENT INFORMATION LEAFLET
PATIENT INFORMATION LEAFLET Page 1 of 6 PATIENT INFORMATION LEAFLET: INFORMATION FOR THE USER Artefan 20/120 * artemether/lumefantrine 20mg/120mg tablets Read all of this leaflet carefully before you start
More informationImodium 1 mg/5 ml oral solution
PACKAGE LEAFLET: INFORMATION FOR THE USER Imodium 1 mg/5 ml oral solution Loperamide hydrochloride Imodium is a registered trademark Read all of this leaflet carefully before you start using this medicine
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. octaplaslg mg/ml solution for infusion Human plasma proteins
PACKAGE LEAFLET: INFORMATION FOR THE USER octaplaslg 45-70 mg/ml solution for infusion Human plasma proteins Read all of this leaflet carefully before you start using this medicine. - Keep this leaflet.
More informationFor further copies of this leaflet, visit emc.medicines.org.uk or call Aspen on +44 (0) Package leaflet: Information for the user
For further copies of this leaflet, visit emc.medicines.org.uk or call Aspen on +44 (0)1 748 828 391. Package leaflet: Information for the user Diprivan 10 mg/ml (1%) Emulsion for Injection or Infusion
More informationDulcolax 5 mg, film-coated tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER Dulcolax 5 mg, film-coated tablets BISACODYL This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which
More information1. What Dobutamine 12.5 mg/ml is and what it is used for
Labelling and Package Leaflet page 1/14 1.3.5 Package Leaflet PACKAGE LEAFLET: INFORMATION FOR THE USER, concentrate for solution for infusion Active substance: dobutamine Read all of this leaflet carefully
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER
PACKAGE LEAFLET: INFORMATION FOR THE USER ARICEPT Evess 5 mg Orodispersible Tablets ARICEPT Evess 10 mg Orodispersible Tablets (Donepezil Hydrochloride) You and your caregiver should read all of this leaflet
More informationPackage leaflet: Information for the user Efedrin Stragen 3mg/ml, solution for injection Ephedrine hydrochloride
Package leaflet: Information for the user Efedrin Stragen 3mg/ml, solution for injection Ephedrine hydrochloride Read all of this leaflet carefully before you start using this medicine because it contains
More information